# BRIDION

NDC: 0006-5423
Generic name: sugammadex
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20151215

FDA application: NDA022225

## Active ingredients

- SUGAMMADEX SODIUM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5423"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5423
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5171d883-fe8f-482c-97ab-40b00975b64a